Publication date: Available online 15 May 2020Source: Radiotherapy and OncologyAuthor(s): Sebastian Zschaeck, Steffen Löck, Frank Hofheinz, Daniel Zips, Lise Saksø Mortensen, Klaus Zöphel, Esther GC Troost, Simon Boeke, Mette Saksø, David Mönnich, Annekatrin Seidlitz, Jørgen Johansen, Tomas Skripcak, Vincent Gregoire, Jens Overgaard, Michael Baumann, Mechthild Krause
Publication date: Available online 15 May 2020Source: Radiotherapy and OncologyAuthor(s): Pierfrancesco Franco, Valentina Tesio, Jenny Bertholet, Anne Gasnier, Elisabet Gonzalez del Portillo, Mateusz Spalek, Jean-Emmanuel Bibault, Gerben Borst, Wouter Van Elmpt, Daniela Thorwarth, Laura Mullaney, Kathrine Røe Redalen, Ludwig Dubois, Cyrus Chargari, Sophie Perryck, Jolien Heukelom, Steven Petit, Myriam Lybeer, Lorys Castelli
Publication date: Available online 15 May 2020Source: Radiotherapy and OncologyAuthor(s): Allison E. Garda, Patrick J. Navin, Kenneth W. Merrell, James A. Martenson, Michelle A. Neben Wittich, Michael G. Haddock, Terence T. Sio, William G. Rule, Jonathan B. Ashman, Shannon P. Sheedy, Christopher L. Hallemeier
Publication date: Available online 15 May 2020Source: Radiotherapy and OncologyAuthor(s): Yungan Tao, Anne Auperin, Pierre Blanchard, Marc Alfonsi, Xu-Shan Sun, Michel Rives, Yoann Pointreau, Joël Castelli, Pierre Graff, Stéphanie Wong Hee Kam, Juliette Thariat, Ovidiu Veresezan, Steve Heymann, Sophie Renard-Oldrini, Cédrik Lafond, Alexandre Cornely, Odile Casiraghi, Pierre Boisselier, Michel Lapeyre, Julian Biau
Publication date: Available online 15 May 2020Source: Radiotherapy and OncologyAuthor(s): Dario Pasalic, Ethan B. Ludmir, Pamela K. Allen, Nikhil G. Thaker, Bhavana V. Chapman, Ehab Y. Hanna, Shirley Y. Su, Renata Ferrarotto, Bonnie S. Glisson, Jay P. Reddy, G. Brandon Gunn, Clifton D. Fuller, Jack Phan, David I. Rosenthal, William H. Morrison, Adam S. Garden, Steven J. Frank
Publication date: Available online 15 May 2020Source: Radiotherapy and OncologyAuthor(s): Benedek Tinusz, Alexandra Soós, Péter Hegyi, Patrícia Sarlós, László Szapáry, Adrienn Erős, Donáta Feczák, Zsolt Szakács, Katalin Márta, Viktória Venglovecz, Bálint Erőss
Publication date: Available online 14 May 2020Source: Radiotherapy and OncologyAuthor(s): Daniel Martin, Franz Rödel, Jens von der Grün, Claus Rödel, Emmanouil Fokas
Publication date: Available online 14 May 2020Source: Radiotherapy and OncologyAuthor(s): Abrahim Al-Mamgani, Rob Kessels, Cornelia G. Verhoef, Arash Navran, Olga Hamming-Vrieze, Johannes H.A.M. Kaanders, Roel J.H.M. Steenbakkers, Lisa Tans, Frank Hoebers, Francisca Ong, Erik van Werkhoven, Johannes A. Langendijk
Mark above section as read
Combination treatments with immunotherapy in brain metastases patients. Future Oncol. 2020 May 15;: Authors: Henon C, Remon J, Hendriks LE Abstract Immune checkpoint inhibitors (ICI) have revolutionized the treatment of many advanced cancers. However, in most pivotal trials, patients with brain metastases (BM) were either excluded, or only selected patients were allowed. Therefore, there are still some concerns about the safety/efficacy ratio of ICI...
Pancreatic cancer in Australia: is not it time we address the inequitable resource problem? Future Oncol. 2020 May 15;: Authors: Barreto SG Abstract The present study reviewed the geographical variations in the delivery of pancreatic cancer therapy and whether this impacts overall survival. The evidence suggests a difference in the accessibility of pancreatic cancer care to patients in rural as compared with urban Australia. While centralization of pancreatic...
The management of patients with metastatic prostate cancer during the COVID-19 pandemic. Future Oncol. 2020 May 15;: Authors: Assi T, Ibrahim N, K Abboud RM, Kattan C, Rassy E, Nemr E, Kattan J Abstract During the ongoing global pandemic of coronavirus disease 2019 (COVID-19), the benefit of treating patients with cancer must be weighed against the COVID-19 infection risks to patients, staff and society. Prostate cancer is one of the most common cancers...
Outcomes of retreatment with anti-PD-1 monotherapy after response to first course in patients with cutaneous melanoma. Future Oncol. 2020 May 15;: Authors: Whitman ED, Scherrer E, Ou W, Krepler C Abstract Aim: To determine outcomes of retreatment with anti-PD-1 monotherapy for melanoma. Materials & methods: This retrospective study included adults with unresectable cutaneous melanoma who achieved stable disease (SD) or better after anti-PD-1 monotherapy...
Cost-effectiveness analysis of nivolumab in the second-line treatment for advanced esophageal squamous cell carcinoma. Future Oncol. 2020 May 14;: Authors: Zhang PF, Xie D, Li Q Abstract Background: To investigate the cost-effectiveness of nivolumab versus chemotherapy in the second-line treatment for advanced esophageal squamous cell carcinoma. Materials & methods: A Markov model reflecting the patients in the ATTRACTION-3 trial was established....
Using biomarkers to determine optimal combinations with immunotherapy (biomarker discovery perspective). Future Oncol. 2020 May 14;: Authors: Teixido C, Reguart N PMID: 32407147 [PubMed - as supplied by publisher]
Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19. Future Oncol. 2020 May 14;: Authors: Sean Ong XR, Condon B, Bagguley D, Lawrentschuk N, Azad A, Murphy D PMID: 32407145 [PubMed - as supplied by publisher]
Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients' care. Future Oncol. 2020 May 14;: Authors: Massari F, Mollica V, Salvagni S, Tognetto M, Ardizzoni A PMID: 32406749 [PubMed - as supplied by publisher]
Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again? Future Oncol. 2020 May 14;: Authors: O'Connor E, Teh J, Kamat AM, Lawrentschuk N PMID: 32406253 [PubMed - as supplied by publisher]
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy). Future Oncol. 2020 May 14;: Authors: Stroppa EM, Toscani I, Citterio C, Anselmi E, Zaffignani E, Codeluppi M, Cavanna L Abstract Background: We describe cancer patients with coronavirus disease-2019 (COVID-19) infection treated at the Piacenza's general hospital (north Italy). Materials & methods: Twenty-five cancer patients infected...
Mark above section as read
Publication date: Available online 15 May 2020Source: BrachytherapyAuthor(s): Christopher L. Deufel, Marina A. Epelman, Kalyan S. Pasupathy, Mustafa Y. Sir, Victor W. Wu, Michael G. Herman
Mark above section as read
Regeneration is a complex mechanism to restore lost or damaged body parts. In earthworms, regeneration capability varies among different species, and it is important to explore the mechanism behind the regeneration process. Interestingly, regeneration in earthworms is either dependent or independent of clitellum segments. In the present study, juvenile earthworms (Eudrilus eugeniae) were amputated at 3 different sites, namely the head, clitellum, and tail segments (at segments 10, 15, and 30, respectively),...
Mark above section as read
Prolyl hydroxylase domain 2 reduction enhances skeletal muscle tissue regeneration after soft tissue trauma in mice. PLoS One. 2020;15(5):e0233261 Authors: Settelmeier S, Schreiber T, Mäki J, Byts N, Koivunen P, Myllyharju J, Fandrey J, Winning S Abstract The transcription factor Hypoxia-inducible factor 1 (HIF-1) plays a pivotal role in tissue regeneration. HIF-1 is negatively controlled by O2-dependent prolyl hydroxylases with a predominant role of...
Related ArticlesEnarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial. Nephron. 2019;143(2):77-85 Authors: Akizawa T, Nangaku M, Yamaguchi T, Arai M, Koretomo R, Maeda K, Miyazawa Y, Hirakata H Abstract BACKGROUND: Enarodustat (JTZ-951) is an orally available hypoxia-inducible factor prolyl hydroxylase inhibitor that increases endogenous erythropoietin...
Mark above section as read
What is the impact of continuous neuromonitoring on the incidence of injury to the recurrent laryngeal nerve during total thyroidectomy? Surgery. 2020 May 11;: Authors: Bihain F, Nomine-Criqui C, Demarquet L, Blanchard C, Gallet P, Nguyen PL, Mirallie E, Brunaud L Abstract BACKGROUND: Continuous intraoperative neuromonitoring may facilitate reversal of intraoperative injurious operative maneuvers in comparison with intermittent intraoperative neuromonitoring....
Controlling porous titanium/soft tissue interactions with an innovative surface chemical treatment: Responses of macrophages and fibroblasts. Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110845 Authors: Barthes J, Cazzola M, Muller C, Dollinger C, Debry C, Ferraris S, Spriano S, Vrana NE Abstract In order to create a stable interface with the host tissue, porous implants are widely used to ensure the in-growth of the cells and the colonization of the...
Mark above section as read
Publication date: Available online 15 May 2020Source: Annals of Diagnostic PathologyAuthor(s): Kwun Wah Wen, Bita Fakhri, Joshua Menke, Roberto Ruiz-Cordero, Ryan M. Gill, Robert S. Ohgami
Mark above section as read
Publication date: Available online 15 May 2020Source: Hearing ResearchAuthor(s): Christian E. Stilp
Mark above section as read
Proximal humeral fracture surgery in the COVID-19 pandemic: advocacy for regional anesthesia. Reg Anesth Pain Med. 2020 May 13;: Authors: Tognù A, Barbara E, Pacini I, Bosco M PMID: 32409516 [PubMed - as supplied by publisher]
The #ASRASpring20 conference was canceled due to COVID-19 but the science survives and thrives. Reg Anesth Pain Med. 2020 May 13;: Authors: Gupta RK, Mariano ER, Narouze S, Elkassabany NM PMID: 32409515 [PubMed - as supplied by publisher]
COVID-19 pandemic: regional anesthesia should be the new norm! Reg Anesth Pain Med. 2020 May 13;: Authors: Mistry T, Singh SK PMID: 32409514 [PubMed - as supplied by publisher]
Mark above section as read
Publication date: Available online 16 May 2020Source: Archives of Oral BiologyAuthor(s): Gabriele Cervino, Marco Cicciù, Rosa De Stefano, Domenico Falcomatà, Alberto Bianchi, Salvatore Crimi, Luigi Laino, Alan Scott Herford, Michele Gaeta, Luca Fiorillo
Publication date: Available online 16 May 2020Source: Archives of Oral BiologyAuthor(s): Xinyi Zhou, Qian Wang, Lulingxiao Nie, Peng Zhang, Pengfei Zhao, Quan Yuan, Ning Ji, Yi Ding, Qi Wang
Publication date: Available online 16 May 2020Source: Archives of Oral BiologyAuthor(s): Flavia Kazue Ibuki, Cassia Toledo Bergamaschi, Marlus da Silva Pedrosa, Fernando Neves Nogueira
Mark above section as read
New England Journal of Medicine, Ahead of Print.
Fri May 15, 2020 07:02
New England Journal of Medicine, Ahead of Print.
Fri May 15, 2020 07:01
New England Journal of Medicine, Ahead of Print.
Fri May 15, 2020 07:01
New England Journal of Medicine, Ahead of Print.
Fri May 15, 2020 07:00
New England Journal of Medicine, Ahead of Print.
Fri May 15, 2020 07:00
Mark above section as read
A Survey of Glaucoma Surgery Practice Patterns in the Veterans Health Administration. Mil Med. 2020 May 15;: Authors: Olivieri DJ, Lynch MG, Cockerham GC, Greenberg PB Abstract INTRODUCTION: Glaucoma surgical practice patterns are not well described in the United States (US). This study aims to evaluate the indications for and potential barriers to glaucoma surgery in the Veterans Health Administration (VHA). MATERIALS AND METHODS: An anonymous...
Mark above section as read
Ventilatory support in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a systematic review and meta-analysis. J Dermatolog Treat. 2020 May 15;:1-17 Authors: Phan K, Oh LJ, Issler-Fisher A, Rao A, Wong EH, Maitz P Abstract Introduction: Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are blistering cutaneous disorders that often manifest with epidermal and mucosal necrosis. In extreme cases, the upper or bronchial airways...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου